Originalarbeiten

Veselinović T, Vernaleken I, Janouschek H, Cumming P, Paulzen M, Mottaghy FM, Gründer G. The role of striatal dopamine D2/3 receptors in cognitive performance in drug-free patients with schizophrenia. Psychopharmacology (Berl) 2018; 235(8): 2221-2232.

Veselinović T, Vernaleken I, Cumming P, Henning U, Winkler L, Kaleta P, Paulzen M, Luckhaus C, Gründer G. Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion. Neuropsychiatr Dis Treat. 2018; 14: 1125-1138.

Paulzen M, Lammertz SE, Gründer G, Veselinovic T, Hiemke C, Tauber SC. Measuring citalopram in blood and central nervous system: revealing a distribution pattern that differs from other antidepressants: Erratum. Int Clin Psychopharmacol 2016; 31(5): 300.

Schoretsanitis G, Haen E, Hiemke C, Gründer G, Stegmann B, Schruers KR, Veselinovic T, Lammertz SE, Paulzen M. Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations? Int Clin Psychopharmacol 2016; 31(5):259-64.

Paulzen M, Gründer G, Veselinovic T, Wolf B, Hiemke C, Lammertz SE. Duloxetine enters the brain - But why is it not found in the cerebrospinal fluid. J Affect Disord 2016; 189: 159-63.

Paulzen M, Lammertz SE, Gründer G, Veselinovic T, Hiemke C, Tauber SC. Measuring citalopram in blood and central nervous system: revealing a distribution pattern that differs from other antidepressants. Int Clin Psychopharmacol 2016; 31(3): 119-26.

► frühere Originalarbeiten

Veselinovic T, Vernaleken I, Janouschek H, Kellermann T, Paulzen M, Cumming P, Gründer G. Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers. Psychopharmacology (Berl) 2015 ; 232(9): 1607-17.

Paulzen M, Groppe S, Tauber SC, Veselinovic T, Hiemke C, Gründer G. Venlafaxine and O-desmethylvenlafaxine concentrations in plasma and cerebrospinal fluid. J Clin Psychiatry 2015; 76(1): 25-31.

Paulzen M, Gründer G, Tauber SC, Veselinovic T, Hiemke C, Groppe SE. Distribution pattern of mirtazapine and normirtazapine in blood and CSF. Psychopharmacology (Berl) 2015; 232(4): 807-13.

Paulzen M, Gründer G, Orlikowsky T, Gräf CM, Hoeltzenbein M, Veselinovic T. Suicide Attempt During Late Pregnancy With Quetiapine: Nonfatal Outcome Despite Severe Intoxication. J Clin Psychopharmacol 2015; 35(3): 343-4.

Paulzen M, Lammertz SE, Veselinovic T, Goecke TW, Hiemke C, Gründer G. Lamotrigine in pregnancy - therapeutic drug monitoring in maternal blood, amniotic fluid, and cord blood. Int Clin Psychopharmacol 2015; 30(5): 249-54.

Gründer G, Veselinovic T, Paulzen M. [Antidepressive agents and suicidal tendencies.] Nervenarzt 2014; 85(9): 1108-16.

Paulzen M, Veselinovic T, Gründer G. Effects of psychotropic drugs on brain plasticity in humans. Restor Neurol Neurosci 2014; 32(1): 163-81.

Veselinovic T, Paulzen M, Gründer G. Cariprazine, a new, orally active dopamine D2/3 receptor partial agonist for the treatment of schizophrenia, bipolar mania and depression. Expert Rev Neurother 2013; 13(11): 1141-59.

Veselinovic T, Schorn H, Vernaleken IB, Hiemke C, Zernig G, Gur R, Gründer G. Effects of antipsychotic treatment on cognition in healthy subjects. J Psychopharmacol 2013; 27(4): 374-385.

Gründer G, Veselinovic T, Paulzen M. [Basic principles of therapy with neuropsychotropic drugs]. Nervenarzt 2012; 83(9): 1193-208.

Veselinovic T, Schorn H, Vernaleken IB, Schiffl K, Klomp M, Gründer G. Impact of different antidopaminergic mechanisms on the dopaminergic control of prolactin secretion. J Clin Psychopharmacol 2011; 31: 214-20.

Gründer G, Hiemke C, Paulzen M, Veselinovic T, Vernaleken I. Therapeutic Plasma Concentrations of Antidepressants and Antipsychotics: Lessons from PET Imaging. Pharmacopsychiatry 2011; 44: 236-48.

Vernaleken I, Janouschek H, Raptis M, Hellmann S, Veselinovic T, Bröcheler A, Boy C, Cumming P, Hiemke C, Rösch F, Schäfer WM, Gründer G. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. Int J Neuropsychopharmacol 2010; 13(7): 951-60.

Veselinovic T, Himmerich H. Antihistaminerge Antipsychotika verursachen Gewichtszunahme. [Antihistaminergic antipsychotics cause weight gain.] Nervenarzt 2010; 81(3): 329-34.

Veselinovic T, Louis F, Himmerich H. Dialektisch-Behaviorale Therapie bei Borderline-Persönlichkeitsstörung Anwendung und Evaluation. psychoneuro 2008; 34 (10): 467-470.

Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone). J Clin Psychopharmacol 2008; 28(6): 608-617.

Gründer G, Fellows C, Janouschek H, Veselinovic T, Boy C, Bröcheler A, Kirschbaum KM, Hellmann S, Spreckelmeyer KM, Hiemke C, Rösch F, Schaefer WM, Vernaleken I. Brain and plasma pharmacokinetics of Aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.Am J Psychiatry 2008; 988-995.

Veselinovic T, Bauer J. The importance of out-patient departments for patients with epilepsy?An evaluation in 503 patients. Z Epileptol 2006; 19: 21-23.

Weitere Informationen zu den wissenschaftlichen Veröffentlichungen entnehmen Sie bitte der Literatur-Datenbank PubMed